Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 03, 2017
Source ID
10.1007/s00109-017-1513-9

Entities

People

  • Alvin H. Schmaier
  • Brian D. Hoit
  • Christoph Maier
  • Christopher A. Flask
  • Daniel Batlle
  • Gregory N. Adams
  • Ines Schadock
  • Jan Wysocki
  • Michael Bader
  • Minghao Ye
  • Philipp K. Haber
  • Xin Yu
  • Yashpal Kanwar

Organizations

  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • United States Department of Defense